• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Norepinephrine in septic shock.

作者信息

Hernández Glenn, Teboul Jean-Louis, Bakker Jan

机构信息

Departmento de Medicina Intensiva, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Service de réanimation médicale, Hopital Bicetre, Hopitaux Universitaires Paris-Sud, Paris, France.

出版信息

Intensive Care Med. 2019 May;45(5):687-689. doi: 10.1007/s00134-018-5499-8. Epub 2019 Jan 10.

DOI:10.1007/s00134-018-5499-8
PMID:30631902
Abstract
摘要

相似文献

1
Norepinephrine in septic shock.脓毒症休克中的去甲肾上腺素
Intensive Care Med. 2019 May;45(5):687-689. doi: 10.1007/s00134-018-5499-8. Epub 2019 Jan 10.
2
Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature.优化感染性休克中的平均动脉压：对文献的批判性重新评估。
Crit Care. 2015 Mar 10;19(1):101. doi: 10.1186/s13054-015-0794-z.
3
Selepressin, a novel selective vasopressin V agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients.塞莱昔醇，一种新型选择性血管加压素 V 激动剂，在脓毒性休克患者的 IIa 期随机、安慰剂对照试验中是去甲肾上腺素的有效替代品。
Crit Care. 2017 Aug 15;21(1):213. doi: 10.1186/s13054-017-1798-7.
4
Treatment of hypotension in septic shock.感染性休克中低血压的治疗。
Lancet. 1996 Mar 2;347(9001):622; author reply 622-3.
5
Comment on "A comparison of epinephrine and norepinephrine in critically Ill patients".关于“危重症患者肾上腺素与去甲肾上腺素的比较”的评论
Intensive Care Med. 2009 Jul;35(7):1310; author reply 1311. doi: 10.1007/s00134-009-1492-6. Epub 2009 Apr 15.
6
Treatment of hypotension in septic shock.感染性休克中低血压的治疗。
Lancet. 1996 Mar 2;347(9001):622-3.
7
Noradrenaline as a vasoactive agent in septic shock.去甲肾上腺素作为脓毒性休克中的血管活性药物。
Intensive Care Med. 2000 May;26(5):648. doi: 10.1007/s001340051222.
8
Severe septic shock unresponsive to noradrenaline.对去甲肾上腺素无反应的严重感染性休克。
Lancet. 1995 Dec 16;346(8990):1604. doi: 10.1016/s0140-6736(95)91933-3.
9
Terlipressin for norepinephrine-resistant septic shock.特利加压素用于去甲肾上腺素抵抗性感染性休克
Lancet. 2002 Apr 6;359(9313):1209-10. doi: 10.1016/S0140-6736(02)08225-9.
10
Is the addition of vasopressin to norepinephrine beneficial for the treatment of septic shock?去甲肾上腺素加用血管加压素对感染性休克治疗有益吗？
Ann Emerg Med. 2013 Nov;62(5):534-535. doi: 10.1016/j.annemergmed.2013.01.031. Epub 2013 May 16.

引用本文的文献

1
Beyond the heart: a review exploring non-cardiovascular effects of vasoactive agents.心脏之外：探索血管活性药物非心血管效应的综述
Front Pharmacol. 2025 Jul 10;16:1533437. doi: 10.3389/fphar.2025.1533437. eCollection 2025.
2
Norepinephrine Infusion and the Central Venous Waveform in a Porcine Model of Endotoxemic Hypotension with Resuscitation: A Large Animal Study.去甲肾上腺素输注与内毒素血症性低血压复苏猪模型中的中心静脉波形：一项大型动物研究
J Invest Surg. 2025 Dec;38(1):2445603. doi: 10.1080/08941939.2024.2445603. Epub 2025 Jan 6.
3
Complex Pathophysiology of Acute Kidney Injury (AKI) in Aging: Epigenetic Regulation, Matrix Remodeling, and the Healing Effects of HS.

本文引用的文献

1
Mean arterial pressure and mortality in patients with distributive shock: a retrospective analysis of the MIMIC-III database.分布性休克患者的平均动脉压与死亡率：一项对多中心重症医学信息数据库-III（MIMIC-III）的回顾性分析
Ann Intensive Care. 2018 Nov 8;8(1):107. doi: 10.1186/s13613-018-0448-9.
2
Unintended Consequences: Fluid Resuscitation Worsens Shock in an Ovine Model of Endotoxemia.意外后果：液体复苏在羊内毒素血症模型中加重休克。
Am J Respir Crit Care Med. 2018 Oct 15;198(8):1043-1054. doi: 10.1164/rccm.201801-0064OC.
3
A global perspective on vasoactive agents in shock.
衰老相关急性肾损伤（AKI）的复杂病理生理学：表观遗传调控、基质重塑和 HS 的修复作用。
Biomolecules. 2024 Sep 17;14(9):1165. doi: 10.3390/biom14091165.
4
Sex- and Gender-Based Analysis on Norepinephrine Use in Septic Shock: Why Is It Still a Male World?脓毒症休克中去甲肾上腺素使用的性别和基于性别的分析：为何仍是男性的世界？
Microorganisms. 2024 Apr 18;12(4):821. doi: 10.3390/microorganisms12040821.
5
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.脓毒性休克的挑战：从新的血流动力学到血液净化疗法
J Pers Med. 2024 Feb 3;14(2):176. doi: 10.3390/jpm14020176.
6
Hemodynamic management of septic shock: beyond the Surviving Sepsis Campaign guidelines.脓毒性休克的血流动力学管理：超越《拯救脓毒症运动》指南
Clin Exp Emerg Med. 2023 Sep;10(3):255-264. doi: 10.15441/ceem.23.065. Epub 2023 Jul 13.
7
2023 Update on Sepsis and Septic Shock in Adult Patients: Management in the Emergency Department.2023年成人脓毒症和感染性休克最新进展：急诊科管理
J Clin Med. 2023 Apr 28;12(9):3188. doi: 10.3390/jcm12093188.
8
Prediction of vasopressor requirement among hypotensive patients with suspected infection: usefulness of diastolic shock index and lactate.疑似感染的低血压患者血管升压药需求的预测：舒张压休克指数和乳酸的作用
Clin Exp Emerg Med. 2022 Sep;9(3):176-186. doi: 10.15441/ceem.22.324. Epub 2022 Sep 30.
9
The effect of continuous intravenous norepinephrine infusion on systemic hemodynamics in a telemetrically-monitored mouse model of sepsis.连续静脉输注去甲肾上腺素对脓毒症遥测监测小鼠模型全身血流动力学的影响。
PLoS One. 2022 Aug 11;17(8):e0271667. doi: 10.1371/journal.pone.0271667. eCollection 2022.
10
Outcomes and Risk Factors of Critically Ill Patients with Hematological Malignancy. Prospective Single-Centre Observational Study.血液恶性肿瘤危重症患者的结局和危险因素。前瞻性单中心观察性研究。
Medicina (Kaunas). 2021 Nov 30;57(12):1317. doi: 10.3390/medicina57121317.
休克中血管活性药物的全球视角
Intensive Care Med. 2018 Jun;44(6):833-846. doi: 10.1007/s00134-018-5242-5. Epub 2018 Jun 4.
4
The Surviving Sepsis Campaign Bundle: 2018 update.拯救脓毒症运动集束化治疗方案：2018年更新版
Intensive Care Med. 2018 Jun;44(6):925-928. doi: 10.1007/s00134-018-5085-0. Epub 2018 Apr 19.
5
Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.评估同时接受去甲肾上腺素和血管加压素输注的感染性休克患者的血管升压药停用策略。
Ann Pharmacother. 2018 Aug;52(8):733-739. doi: 10.1177/1060028018765187. Epub 2018 Mar 21.
6
Norepinephrine exerts an inotropic effect during the early phase of human septic shock.去甲肾上腺素在人类感染性休克的早期阶段发挥变力作用。
Br J Anaesth. 2018 Mar;120(3):517-524. doi: 10.1016/j.bja.2017.11.065. Epub 2017 Nov 21.
7
Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock.升压治疗脓毒性和血管扩张性休克时较高与较低血压目标值的汇总分析。
Intensive Care Med. 2018 Jan;44(1):12-21. doi: 10.1007/s00134-017-5016-5. Epub 2017 Dec 19.
8
Ventriculo-Arterial Coupling Analysis Predicts the Hemodynamic Response to Norepinephrine in Hypotensive Postoperative Patients: A Prospective Observational Study.心室-动脉耦合分析预测低血压术后患者对去甲肾上腺素的血流动力学反应：一项前瞻性观察研究。
Crit Care Med. 2018 Jan;46(1):e17-e25. doi: 10.1097/CCM.0000000000002772.
9
Septic shock and the use of norepinephrine in an intermediate care unit: Mortality and adverse events.脓毒性休克及去甲肾上腺素在中级护理病房的应用：死亡率及不良事件
PLoS One. 2017 Aug 24;12(8):e0183073. doi: 10.1371/journal.pone.0183073. eCollection 2017.
10
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.拯救脓毒症运动：脓毒症和脓毒性休克管理国际指南：2016 年版。
Intensive Care Med. 2017 Mar;43(3):304-377. doi: 10.1007/s00134-017-4683-6. Epub 2017 Jan 18.